These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 8206997)

  • 1. Functional human saposins expressed in Escherichia coli. Evidence for binding and activation properties of saposins C with acid beta-glucosidase.
    Qi X; Leonova T; Grabowski GA
    J Biol Chem; 1994 Jun; 269(24):16746-53. PubMed ID: 8206997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ex vivo localization of the mouse saposin C activation region for acid beta-glucosidase.
    Qi X; Kondoh K; Yin H; Wang M; Ponce E; Sun Y; Grabowski GA
    Mol Genet Metab; 2002 Jul; 76(3):189-200. PubMed ID: 12126932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation, characterization, and proteolysis of human prosaposin, the precursor of saposins (sphingolipid activator proteins).
    Hiraiwa M; O'Brien JS; Kishimoto Y; Galdzicka M; Fluharty AL; Ginns EI; Martin BM
    Arch Biochem Biophys; 1993 Jul; 304(1):110-6. PubMed ID: 8323276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional organization of saposin C. Definition of the neurotrophic and acid beta-glucosidase activation regions.
    Qi X; Qin W; Sun Y; Kondoh K; Grabowski GA
    J Biol Chem; 1996 Mar; 271(12):6874-80. PubMed ID: 8636113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human acid beta-glucosidase. Use of inhibitory and activating monoclonal antibodies to investigate the enzyme's catalytic mechanism and saposin A and C binding sites.
    Fabbro D; Grabowski GA
    J Biol Chem; 1991 Aug; 266(23):15021-7. PubMed ID: 1714449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of calcium on phosphatidylserine- and saposin C-stimulated glucosylceramide beta-glucosidase activity.
    Prence EM
    Biochem J; 1995 Sep; 310 ( Pt 2)(Pt 2):571-5. PubMed ID: 7654196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Saposin C is required for normal resistance of acid beta-glucosidase to proteolytic degradation.
    Sun Y; Qi X; Grabowski GA
    J Biol Chem; 2003 Aug; 278(34):31918-23. PubMed ID: 12813057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a mutation in a family with saposin B deficiency: a glycosylation site defect.
    Kretz KA; Carson GS; Morimoto S; Kishimoto Y; Fluharty AL; O'Brien JS
    Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2541-4. PubMed ID: 2320574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of saposins, acidic lipids, and glucosylceramidase.
    Morimoto S; Kishimoto Y; Tomich J; Weiler S; Ohashi T; Barranger JA; Kretz KA; O'Brien JS
    J Biol Chem; 1990 Feb; 265(4):1933-7. PubMed ID: 2298731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural analysis of saposin C and B. Complete localization of disulfide bridges.
    Vaccaro AM; Salvioli R; Barca A; Tatti M; Ciaffoni F; Maras B; Siciliano R; Zappacosta F; Amoresano A; Pucci P
    J Biol Chem; 1995 Apr; 270(17):9953-60. PubMed ID: 7730378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential membrane interactions of saposins A and C: implications for the functional specificity.
    Qi X; Grabowski GA
    J Biol Chem; 2001 Jul; 276(29):27010-7. PubMed ID: 11356836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of human saposin B sphingolipid-binding specificity by alternative splicing. A study with saposin B-derived synthetic peptides.
    Lamontagne S; Potier M
    J Biol Chem; 1994 Aug; 269(32):20528-32. PubMed ID: 8051151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of recombinant human saposin A expressed by Pichia pastoris.
    Yamada M; Inui K; Hamada D; Nakahira K; Yanagihara K; Sakai N; Nishigaki T; Ozono K; Yanagihara I
    Biochem Biophys Res Commun; 2004 May; 318(2):588-93. PubMed ID: 15120640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acid beta-glucosidase: intrinsic fluorescence and conformational changes induced by phospholipids and saposin C.
    Qi X; Grabowski GA
    Biochemistry; 1998 Aug; 37(33):11544-54. PubMed ID: 9708990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformational and amino acid residue requirements for the saposin C neuritogenic effect.
    Qi X; Kondoh K; Krusling D; Kelso GJ; Leonova T; Grabowski GA
    Biochemistry; 1999 May; 38(19):6284-91. PubMed ID: 10320358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Saposin A: second cerebrosidase activator protein.
    Morimoto S; Martin BM; Yamamoto Y; Kretz KA; O'Brien JS; Kishimoto Y
    Proc Natl Acad Sci U S A; 1989 May; 86(9):3389-93. PubMed ID: 2717620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and characterization of prosaposin from human milk.
    Kondoh K; Hineno T; Sano A; Kakimoto Y
    Biochem Biophys Res Commun; 1991 Nov; 181(1):286-92. PubMed ID: 1958198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of splicing for prosaposin sorting.
    Madar-Shapiro L; Pasmanik-Chor M; Vaccaro AM; Dinur T; Dagan A; Gatt S; Horowitz M
    Biochem J; 1999 Feb; 337 ( Pt 3)(Pt 3):433-43. PubMed ID: 9895286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sphingolipid hydrolase activator proteins and their precursors.
    Sano A; Hineno T; Mizuno T; Kondoh K; Ueno S; Kakimoto Y; Inui K
    Biochem Biophys Res Commun; 1989 Dec; 165(3):1191-7. PubMed ID: 2610686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the binding and activating sites of the sphingolipid activator protein, saposin C, with glucocerebrosidase.
    Weiler S; Kishimoto Y; O'Brien JS; Barranger JA; Tomich JM
    Protein Sci; 1995 Apr; 4(4):756-64. PubMed ID: 7613473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.